abstract |
The present invention relates to pyrrolidine-2-carboxamide derivatives of formula (I) which act as antagonists of mdm2 interactions and are useful as potent and selective anticancer agents: (I) In this formula, R 1 , R 2 , R 3 , R 3 , R 4 and R 5 are as defined herein. |